Tecan Group Stock

Tecan Group AG engages in the development, production, and distribution of enabling solutions for the discovery of pharmaceutical substances, as well as genomics, proteomics, and diagnostics. It provides platforms for the automation of laboratory processes. The company focuses on liquid handling, and detection devices, as well as it provides options for system integration. Tecan also develops and manufactures components for use by other enterprises.

Automated Liquid handling

The company produces liquid handling and laboratory automation solutions for the clinical diagnostic and biopharmaceutical markets, as well as for corporate account and Original Equipment Manufacturer (OEM) customers.

The company’s Freedom EVO series integrates a range of Tecan instrumentation, as well as products from other third party manufacturers. These solutions offer accurate positioning for liquid handling operations, as well as the ability to integrate a range of miniaturization technologies.

In early 2004, the company launched the Freedom EVO 75 platform. It provides automation solution for customers needing liquid handling on a scale suitable for smaller laboratory settings.

Biopharmacy applications

Genomics: Tecan solutions help in translating genomic information into medical interventions.

Proteomics: It is allowing more direct routes to disease targets, new drugs and diagnostics.

Drug discovery: Providing tools to speed the drug discovery and development process.

Microarray scanners: In September 2004, the company introduced LS Reloaded, a series of automation microarray scanners. It introduced LaserCheck, a kit that permits convenient automatic quality control of LS Reloaded operation through calibration of microarray scanning.

Cellerity: Cellerity is an automated high-throughput cell and protein production system for cell culture maintenance, cellline expansion and harvesting.

Diagnostics applications

Tecan has focused its diagnostic application business on four segments of the global diagnostics market – Blood Grouping, Immunology, Laboratory Logistics and Molecular Diagnostics. In the worldwide blood banking market, Tecan is a supplier of front-end automation systems for Nucleic Acid Testing (NAT) for blood screening.

Laboratory logistics: It delivers laboratory automation solutions for sample preparation and processing.

Blood grouping: Tecan provides a range of automated applications for blood grouping and blood typing.

Molecular Diagnostics: Tecan solutions allow automation of diagnostic tests.

Immunology: Tecan provides automated tools to immunological testing for diseases like HIV and hepatitis C.

Tecan offers a range of In Vitro Diagnostic Directive (IVD-D) compliant platforms and solutions. Early 2004, the Freedom EVO Clinical series of automated platforms was introduced. The scalable, upgradeable Freedom EVO Clinical series of platforms allow its customers to make use of the products and solutions that enable automated applications. This includes applications for sample preparation, sample distribution, blood typing and pooling, as well as a range of molecular diagnostic applications.

Components

The company provides third party solutions to many companies engaged in the life sciences. Component OEM1 products are used by other manufacturers of laboratory instruments and consumables to build solutions serving the needs of their immediate clients. Tecan produces a variety of products, such as high-precision pumps, robotic system components for laboratory automation, as well as application development software.

Detection

Tecan detection solutions serve a range of applications, on any scale, for drug discovery and clinical diagnostics, as well as basic research. In 2004, the company launched Safire2, a detection instrument for applications in fundamental research, assay development and drug screening.

Customer Support and Customized Applications

Tecan provides care and support services to its customers across the globe. This spans both the development and introduction of new solutions in the life sciences, as well as support throughout the lifetime of all Tecan projects. The company offers installation services, preventive maintenance resources, and a range of repair services.

Sales

The company operates manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in approximately 52 countries. It also has presence in Asia.

Customers

Tecan’s clients are pharmaceutical and biotechnology companies, university and research laboratories, as well as diagnostic laboratories. It serves the Life Science supply industry.

Significant Events

The company is collaborating with tissue engineering researchers at Universität Zürich to develop an automated system for propagation of quality controlled cells that will be suitable for use in regenerative medicine therapies, such as intervertebral disc implants.

In July 2009, Tecan Group Ltd. has entered into an agreement with pION Inc. for the joint development of automated drug screening solutions. Under the agreement, pION has combined its Double-Sink parallel artificial membrane permeability assay (PAMPA) with Tecan' Freedom EVO platform and Infinite M200 plate reader in the PAMPA Evolution, for the development of automated solutions for drug permeability and solubility screening.

History

Tecan Group AG was founded in 1980.